Hormone responsive tissue culture system and uses thereof
View Patent ↗The invention provides tissue culture system for primary cells (e.g. normal mammalian primary epithelial progenitors). This system includes: a) a serum-free, chemically defined cell culture media; and, b) methods for isolation and in vitro long-term propagation of primary cells (e.g. primary epithelial cells). Primary cells so isolated and cultured can be kept undifferentiated and proliferate for many weeks (>15 weeks) or population doubling (>35 PD) without senescence, or any detectable genetic alterations. Upon changing media/culture conditions, these cells can be induced to differentiate. The invention also provides methods to transform normal primary cells so cultured into “cancer stem cells.” The genetically defined cancer stem cell tumor model mimics the behavior of the disease closely, e.g., the cells are invasive, hormone responsive and metastatic when injected into mice. The tumor cells express genes that are specific to cancer stem cells identified in patient samples.
1. A cell culture medium that supports proliferation of tumorigenic, transformed primary breast epithelial progenitor cells, comprising:
(a) vitamin A, vitamin C, and vitamin D;
(b) Zn, Mg, and Cu;
(c) transferrin;
(d) selenium;
(e) cholesterol, linoleic acid, and lipoic acid;
(0 hydrocortisone and estrogen;
(g) triiodothyronine;
(h) a carrier protein;
(i) glutathione;
(j) adenosine triphosphate;
(k) phosphoethanolamine;
(l) a nucleotide salvage pathway precursor base selected from the group consisting of hypoxanthine, xanthine, adenine, guanine and thymidine;
(m) insulin; and
(n) epidermal growth factor,
wherein the medium is free of animal serum and tissue extracts and supports proliferation of tumorigenic, transformed primary breast epithelial progenitor cells for at least about 35 population doublings (PD) in vitro.
2. The culture medium of claim 1 , wherein the carrier protein is albumin.
3. The culture medium of claim 1 , wherein the estrogen is 17-beta-estradiol.
4. The cell culture medium of claim 1 , wherein said medium also contains vitamin E.
5. The culture medium of claim 1 , further comprising adenosine monophosphate.
6. The culture medium of claim 5 , wherein the estrogen is 17-beta-estradiol.
7. The cell culture medium of any of claims 1 - 4 , wherein said medium also contains an agent that increases intracellular cAMP.
8. The cell culture medium of claim 7 , wherein said agent is cholera toxin.
9. The culture medium of claim 1 , wherein the nucleotide salvage pathway precursor base is xanthine or hypoxanthine.
10. The culture medium of claim 9 , wherein the culture medium comprises xanthine and hypoxanthine.
11. The culture medium of claim 1 , further comprising at least one of vitamin K3, niacin, or niacinamide.
12. The cell culture medium of claim 1 , wherein said tumorigenic transformed primary breast epithelial progenitor cells have been induced to express a telomerase catalytic subunit.
13. The cell culture medium of claim 12 , wherein said telomerase catalytic subunit is hTERT.
14. The cell culture medium of claim 1 , wherein said tumorigenic transformed primary breast epithelial cells have been induced to express: (1) telomerase catalytic subunit, (2) a first polypeptide that functions in the same signaling pathway(s) as the SV40 large T antigen, and (3) a second polypeptide that functions in the same signaling pathway as the mutant H-ras oncogene product.
15. The cell culture medium of claim 14 , wherein said telomerase catalytic subunit is hTERT.
16. The cell culture medium of claim 14 or 15 , wherein the first polypeptide is selected from large T antigen and small t antigens.
17. The cell culture medium of claim 16 , wherein the second polypeptide is H-ras.
18. A composition comprising the cell culture medium of claim 1 and tumorigenic, transformed primary breast epithelial progenitor cells.
19. A method of preparing a cell culture medium that supports proliferation of tumorigenic, transformed primary breast epithelial progenitor cells, comprising combining:
(a) vitamin A, vitamin C, and vitamin D;
(b) Zn, Mg, and Cu;
(c) transferrin;
(d) selenium;
(e) cholesterol, linoleic acid, and lipoic acid;
(f) hydrocortisone and estrogen;
(g) triiodothyronine;
(h) a carrier protein;
(i) glutathione;
(j) adenosine triphosphate;
(k) phosphoethanolamine;
(l) a nucleotide salvage pathway precursor base selected from the group consisting of hypoxanthine, xanthine, adenine, guanine and thymidine;
(m) insulin; and
(n) epidermal growth factor,
wherein the medium is free of animal serum and tissue extracts and supports proliferation of tumorigenic, transformed primary breast epithelial progenitor cells for at least about 35 population doublings (PD) in vitro.
20. A cell culture medium that supports proliferation of normal primary breast epithelial cells, comprising:
(a) vitamin A, vitamin C, vitamin D, and vitamin E;
(b) Zn, Mg, and Cu;
(c) transferrin;
(d) selenium;
(e) cholesterol, linoleic acid, and lipoic acid;
(f) hydrocortisone and estrogen;
(g) triiodothyronine;
(h) a carrier protein;
(i) an agent that increases intracellular cAMP;
(j) glutathione;
(k) adenosine triphosphate;
(l) phosphoethanolamine;
(m) a nucleotide salvage pathway precursor base selected from the group consisting of hypoxanthine, xanthine, adenine, guanine and thymidine;
(n) insulin; and
(o) epidermal growth factor,
wherein the medium is free of animal serum and tissue extracts and supports proliferation of normal primary breast epithelial cells for at least about 35 population doublings (PD) in vitro.
21. The culture medium of claim 20 , wherein the carrier protein is albumin.
22. The culture medium of claim 20 , wherein the agent that increases intracellular cAMP is cholera toxin.
23. The culture medium of claim 20 , wherein the estrogen is 17-beta-estradiol.
24. The culture medium of claim 20 , further comprising adenosine monophosphate.
25. The culture medium of claim 24 , wherein the estrogen is 17-beta-estradiol.
26. The culture medium of claim 20 , wherein the nucleotide salvage pathway precursor base is xanthine or hypoxanthine.
27. The culture medium of claim 20 , wherein the culture medium comprises xanthine and hypoxanthine.
28. The culture medium of claim 20 , further comprising at least one of vitamin K3, niacin, or niacinamide.
29. A composition comprising the cell culture medium of claim 20 and normal primary breast epithelial cells.
30. A method of subculturing isolated normal primary breast epithelial cells from a mammal, the method comprising:
(a) harvesting isolated and cultured normal primary breast epithelial cells;
(b) resuspending harvested primary cells obtained in (a) in the medium of claim 20 supplemented with a trypsin inhibitor;
(c) plating resuspended cells produced in (b) on a tissue culture container with mixed (+/−) charge surface, thereby producing a tissue culture container plated with resuspended primary cells in medium; and
(d) replacing medium in the tissue culture container with fresh medium of claim 20 , once the plated resuspended primary cells attach to the surface of the tissue culture container.
31. A method of preparing a cell culture medium that supports proliferation of normal primary breast epithelial cells, comprising combining:
(a) vitamin A, vitamin C, vitamin D, and vitamin E;
(b) Zn, Mg, and Cu;
(c) transferrin;
(d) selenium;
(e) cholesterol, linoleic acid, and lipoic acid;
(f) hydrocortisone and estrogen;
(g) triiodothyronine;
(h) a carrier protein;
(i) an agent that increases intracellular cAMP;
(j) glutathione;
(k) adenosine triphosphate;
(l) phosphoethanolamine;
(m) a nucleotide salvage pathway precursor base selected from the group consisting of hypoxanthine, xanthine, adenine, guanine and thymidine;
(n) insulin; and
(o) epidermal growth factor,
wherein the medium is free of animal serum and tissue extracts and supports proliferation of normal primary breast epithelial cells for at least about 35 population doublings (PD) in vitro.